• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体C1q——有多少种功能?有多少种受体?

C1q--how many functions? How many receptors?

作者信息

Eggleton P, Reid K B, Tenner A J

机构信息

Dept of Biochemistry, University of Oxford, UK.

出版信息

Trends Cell Biol. 1998 Nov;8(11):428-31. doi: 10.1016/s0962-8924(98)01373-7.

DOI:10.1016/s0962-8924(98)01373-7
PMID:9854308
Abstract

C1, the first component of the classical pathway of complement activation is a complex of three proteins called C1q, C1r and C1s. Normally, C1q binding to aggregated IgG molecules results in activation of the classical pathway of complement. However, C1q has a number of other observed functions, not directly related to complement, that could be mediated by recently identified binding proteins acting as cell-surface receptors or soluble modulators of C1q-mediated functions. This article discusses the various activities of C1q and the evidence that these functions might be influenced by both membrane-bound and soluble C1q-binding proteins.

摘要

C1是补体激活经典途径的首个成分,是一种由C1q、C1r和C1s三种蛋白质组成的复合物。正常情况下,C1q与聚集的IgG分子结合会导致补体经典途径的激活。然而,C1q还有许多其他已观察到的功能,这些功能与补体并无直接关联,可能由最近鉴定出的作为细胞表面受体或C1q介导功能的可溶性调节剂的结合蛋白介导。本文讨论了C1q的各种活性,以及这些功能可能受到膜结合型和可溶性C1q结合蛋白影响的证据。

相似文献

1
C1q--how many functions? How many receptors?补体C1q——有多少种功能?有多少种受体?
Trends Cell Biol. 1998 Nov;8(11):428-31. doi: 10.1016/s0962-8924(98)01373-7.
2
C1q-binding proteins and C1q receptors.C1q结合蛋白与C1q受体。
Curr Opin Immunol. 1999 Feb;11(1):42-6. doi: 10.1016/s0952-7915(99)80008-9.
3
Interaction of C1q, and other proteins containing collagen-like domains, with the C1q receptor.C1q以及其他含有胶原样结构域的蛋白质与C1q受体的相互作用。
Biochem Soc Trans. 1990 Dec;18(6):1145-8. doi: 10.1042/bst0181145.
4
Expression and function of C1q receptors and C1q binding proteins at the cell surface.细胞表面C1q受体和C1q结合蛋白的表达与功能
Immunobiology. 2002 Sep;205(4-5):407-20. doi: 10.1078/0171-2985-00142.
5
The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization.C1q结合细胞膜蛋白cC1q-R和gC1q-R从活化细胞中释放:亚细胞分布及免疫化学特性
Clin Immunol Immunopathol. 1997 Jul;84(1):17-26. doi: 10.1006/clin.1997.4374.
6
C1q receptors and endothelial cell activation.C1q受体与内皮细胞活化
J Lab Clin Med. 1999 Jun;133(6):520-2. doi: 10.1016/s0022-2143(99)90179-8.
7
Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG.血小板在全血中以及在存在免疫复合物或聚集的IgG的情况下与C1q的相互作用。
Clin Immunol Immunopathol. 1992 Apr;63(1):45-50. doi: 10.1016/0090-1229(92)90092-3.
8
Identification and characterisation of C1q-binding phage displayed peptides.
Biol Chem. 1997 Dec;378(12):1509-19. doi: 10.1515/bchm.1997.378.12.1509.
9
Interaction of C1q and the collectins with the potential receptors calreticulin (cC1qR/collectin receptor) and megalin.C1q和凝集素与潜在受体钙网蛋白(cC1qR/凝集素受体)和巨膜蛋白的相互作用。
Immunobiology. 1998 Aug;199(2):208-24. doi: 10.1016/s0171-2985(98)80028-4.
10
FN-C1q and C1 INH C1r-C1s complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia.
Immunol Lett. 1989 Jul;22(1):1-6. doi: 10.1016/0165-2478(89)90133-8.

引用本文的文献

1
D-Glutamate production by stressed Escherichia coli gives a clue for the hypothetical induction mechanism of the ALS disease.应激大肠杆菌产生 D-谷氨酸为 ALS 疾病的假设诱导机制提供了线索。
Sci Rep. 2024 Aug 6;14(1):18247. doi: 10.1038/s41598-024-68645-8.
2
Dengue virus infection - a review of pathogenesis, vaccines, diagnosis and therapy.登革热病毒感染——发病机制、疫苗、诊断和治疗的综述。
Virus Res. 2023 Jan 15;324:199018. doi: 10.1016/j.virusres.2022.199018. Epub 2022 Dec 7.
3
Detection of Complement C1q B Chain Overexpression and Its Latent Molecular Mechanisms in Cervical Cancer Tissues Using Multiple Methods.
多种方法检测宫颈癌组织中补体C1q B链过表达及其潜在分子机制
Int J Genomics. 2022 Oct 20;2022:8775330. doi: 10.1155/2022/8775330. eCollection 2022.
4
Neutralizing Antibodies and Antibody-Dependent Enhancement in COVID-19: A Perspective.新冠病毒中的中和抗体与抗体依赖增强作用:一种观点
J Indian Inst Sci. 2022;102(2):671-687. doi: 10.1007/s41745-021-00268-8. Epub 2022 Feb 4.
5
A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection.补体成分 C1q 介导的抗体依赖性增强埃博拉病毒感染的机制。
PLoS Negl Trop Dis. 2020 Sep 4;14(9):e0008602. doi: 10.1371/journal.pntd.0008602. eCollection 2020 Sep.
6
Globular C1q Receptor (gC1qR/p32/HABP1) Suppresses the Tumor-Inhibiting Role of C1q and Promotes Tumor Proliferation in 1q21-Amplified Multiple Myeloma.球形 C1q 受体 (gC1qR/p32/HABP1) 抑制 C1q 的抑瘤作用并促进 1q21 扩增多发性骨髓瘤中的肿瘤增殖。
Front Immunol. 2020 Jul 14;11:1292. doi: 10.3389/fimmu.2020.01292. eCollection 2020.
7
Complement C1q stimulates the progression of hepatocellular tumor through the activation of discoidin domain receptor 1.补体 C1q 通过激活盘状结构域受体 1 促进肝细胞肿瘤的进展。
Sci Rep. 2018 Mar 20;8(1):4908. doi: 10.1038/s41598-018-23240-6.
8
Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients.用于预测多发性骨髓瘤患者对含硼替佐米诱导方案反应的新型蛋白质生物标志物组合
BBA Clin. 2017 Jun 7;8:28-34. doi: 10.1016/j.bbacli.2017.05.003. eCollection 2017 Dec.
9
Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective.早期免疫反应独立于青光眼视网膜神经节细胞功能障碍,补体成分C3具有保护作用。
Proc Natl Acad Sci U S A. 2017 May 9;114(19):E3839-E3848. doi: 10.1073/pnas.1608769114. Epub 2017 Apr 26.
10
Fc receptors in antibody-dependent enhancement of viral infections.抗体依赖性病毒感染增强中的Fc受体
Immunol Rev. 2015 Nov;268(1):340-64. doi: 10.1111/imr.12367.